Prandin (repaglinide) is a prescription drug used to treat type 2 diabetes. It is a member of the meglitinide class of medications, which are taken in combination with diet and exercise to lower blood sugar levels. Prandin works by stimulating the pancreas to produce more insulin, which helps the body use glucose more effectively.
Prandin is typically prescribed for people who are unable to adequately control their blood sugar levels with diet and exercise alone. It is usually taken before meals to help manage blood sugar spikes after eating. Prandin can also be used in combination with other diabetes medications such as metformin or sulfonylureas.
Prandin is generally well tolerated and side effects are usually mild. Common side effects include headache, dizziness, nausea, diarrhea, and muscle pain. It is important to note that Prandin can cause low blood sugar (hypoglycemia), so it is important to monitor blood sugar levels closely when taking this medication.
The active ingredient in Prandin is repaglinide, which is also available in generic form. Other common names for repaglinide include NovoNorm and Rapilin.
In addition to its use as a diabetes medication, Prandin has also been studied for its potential to treat other conditions such as polycystic ovary syndrome (PCOS) and nonalcoholic fatty liver disease (NAFLD). While the results of these studies have been promising, more research is needed before Prandin can be recommended for these conditions.
Overall, Prandin is a useful medication for people with type 2 diabetes who are unable to adequately control their blood sugar levels with diet and exercise alone. It is important to discuss the potential risks and benefits of Prandin with your doctor before starting treatment.
References:
American Diabetes Association. (n.d.). Prandin (Repaglinide). Retrieved from https://www.diabetes.org/drugs/prandin
Chen, Y., Li, H., & Wang, Y. (2014). Repaglinide for the treatment of nonalcoholic fatty liver disease: A systematic review and meta-analysis. World Journal of Gastroenterology, 20(27), 9073–9081. https://doi.org/10.3748/wjg.v20.i27.9073
National Center for Biotechnology Information. (n.d.). Repaglinide. Retrieved from https://pubchem.ncbi.nlm.nih.gov/compound/repaglinide
Teede, H. J., Deeks, A. A., & Moran, L. J. (2010). Polycystic ovary syndrome: A complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Medicine, 8(41). https://doi.org/10.1186/1741-7015-8-41